Sarepta Therapeutics Inc
Score: Negative (33)
18 days at current score.
Downgraded from Neutral on November 17th 2018
- This company ranked negatively compared to the Healthcare sector despite 2 positive IHS Markit Categories
- ETFs holding this stock are seeing positive inflows
- Bearish sentiment is moderate and declining
- Economic output in this company's sector is expanding
Short interest | Neutral
Short interest is moderately high for SRPT with between 10 and 15% of shares outstanding currently on loan. However, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on November 30.
ETF/Index ownership | Positive
ETF activity is positive. Over the last month, ETFs holding SRPT are favorable, with net inflows of $2.85 billion. Additionally, the rate of inflows is increasing.
PMI by IHS Markit | Positive
According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year.
Credit default swap
CDS data is not available for this security.
Please send all inquiries related to the report to firstname.lastname@example.org.
Charts and report PDFs will only be available for 30 days after publishing.
This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.